• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mortality trends and causes of death in diabetic patients.

作者信息

Fuller J H

机构信息

Department of Epidemiology and Public Health, University College London Medical School, UK.

出版信息

Diabete Metab. 1993;19(1 Pt 2):96-9.

PMID:8314434
Abstract

Although national mortality statistics for diabetes mellitus are often quoted in the literature, problems with their validation need to be overcome. They are based upon the assignment of diabetes as the so-called "underlying cause of death", which has several limitations when applied to studies of diabetes mortality. The EURODIAB Sub-Area C study group has carried out simulation studies which indicate that European variations in physicians' certifying practices and national coding procedures could explain about 35% of the variation in published European mortality rates for diabetes. Some of these problems can be overcome by the use of a "multiple-cause" encoding procedure which is recommended for monitoring of the targets of the St Vincent Declaration Action Programme for Europe. Studies of specific causes of death in cohorts of subjects with insulin-dependent diabetes mellitus indicate that many of these premature deaths are potentially avoidable. The major cause of death in patients with non-insulin-dependent diabetes continues to be cardiovascular disease. Studies in England and Wales indicate the diabetic patients are not experiencing the same fall in cardiovascular mortality as that experienced by the general population.

摘要

相似文献

1
Mortality trends and causes of death in diabetic patients.
Diabete Metab. 1993;19(1 Pt 2):96-9.
2
Diabetes mellitus as a cause of death in sub-Saharan Africa: results of a community-based study in Tanzania. The Adult Morbidity and Mortality Project.糖尿病作为撒哈拉以南非洲地区的死因:坦桑尼亚一项基于社区研究的结果。成人发病率和死亡率项目。
Diabet Med. 1996 Nov;13(11):990-4. doi: 10.1002/(SICI)1096-9136(199611)13:11<990::AID-DIA265>3.0.CO;2-4.
3
Recent developments in diabetes epidemiology in Europe.欧洲糖尿病流行病学的最新进展。
World Health Stat Q. 1992;45(4):350-4.
4
Analysis of mortality in French diabetic patients from death certificates: a comparative study.基于死亡证明的法国糖尿病患者死亡率分析:一项对比研究。
Diabetes Metab. 1999 Nov;25(5):404-11.
5
Excess mortality due to diabetes in Mississippi and the estimated extent of underreporting on death certificates.密西西比州因糖尿病导致的超额死亡率及死亡证明上报不足的估计程度。
J Miss State Med Assoc. 2003 Oct;44(10):319-25.
6
Trends in mortality rates for death-certificate-coded diabetes mellitus in an English population 1979-99.1979 - 1999年英国人群中死亡证明编码的糖尿病死亡率趋势。
Diabet Med. 2004 Aug;21(8):936-9. doi: 10.1111/j.1464-5491.2004.01226.x.
7
Diabetes mortality in Singapore, 1991--a preliminary study.1991年新加坡的糖尿病死亡率——一项初步研究。
Singapore Med J. 1998 Jul;39(7):311-8.
8
[Analysis of diabetes-related mortality in France (1970-1987) from multiple causes of death].[法国(1970 - 1987年)多种死因导致的糖尿病相关死亡率分析]
Diabete Metab. 1991 May-Jun;17(3):337-45.
9
Identifying subgroups of the general population that may be susceptible to short-term increases in particulate air pollution: a time-series study in Montreal, Quebec.识别普通人群中可能易受短期颗粒物空气污染增加影响的亚组:魁北克省蒙特利尔市的一项时间序列研究
Res Rep Health Eff Inst. 2000 Oct(97):7-113; discussion 115-20.
10
Causes of mortality in diabetes mellitus: data from a tertiary teaching hospital in India.糖尿病的死亡原因:来自印度一家三级教学医院的数据。
Postgrad Med J. 2009 May;85(1003):227-32. doi: 10.1136/pgmj.2008.067975.

引用本文的文献

1
HO Mediates VEGF- and Flow-Induced Dilations of Coronary Arterioles in Early Type 1 Diabetes: Role of Vascular Arginase and PI3K-Linked eNOS Uncoupling.HO 介导 1 型糖尿病早期血管紧张素诱导的冠状动脉扩张:血管精氨酸酶和 PI3K 相关 eNOS 解耦联的作用。
Int J Mol Sci. 2022 Dec 28;24(1):489. doi: 10.3390/ijms24010489.
2
Burden attributable to Cardiometabolic Diseases in Zimbabwe: a retrospective cross-sectional study of national mortality data.津巴布韦心脏代谢疾病所致负担:一项基于全国死亡率数据的回顾性横断面研究
BMC Public Health. 2015 Dec 7;15:1213. doi: 10.1186/s12889-015-2554-z.
3
The efficacy and safety of Simvastatin in the treatment of lipid abnormalities in diabetes mellitus.
辛伐他汀治疗糖尿病脂质异常的疗效与安全性。
Indian J Endocrinol Metab. 2013 Jan;17(1):105-9. doi: 10.4103/2230-8210.107817.
4
Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.对患有2型糖尿病且伴有其他动脉粥样硬化危险因素的无症状患者进行冠心病筛查的成本效益分析。
J Gen Intern Med. 2004 Dec;19(12):1181-91. doi: 10.1111/j.1525-1497.2004.40012.x.
5
A risk-benefit assessment of metformin in type 2 diabetes mellitus.二甲双胍用于2型糖尿病的风险效益评估。
Drug Saf. 1999 Jun;20(6):489-503. doi: 10.2165/00002018-199920060-00003.
6
Evaluating the terminology requirements to support multi-disciplinary diabetes care.评估支持多学科糖尿病护理的术语要求。
Proc AMIA Annu Fall Symp. 1997:645-9.